Pharmaceuticals
Glenmark wins favourable interim order in deal with Napo
14 Jan 2012
In a significant positive for Glenmark Pharmaceuticals Ltd, its US partner in a drug development and marketing agreement, Napo Pharmaceuticals Inc, will not be able to terminate a deal thanks to an arbitration order
Bristol-Myers to acquire hepatitis C oral drug developer Inhibitex for $2.5 bn
09 Jan 2012
Bristol-Myers Squibb over the weekend said that it will buy Inhibitex Inc, for about $2.5 billion in cash in order to expand its broad hepatitis C portfolio
Zydus Cadila acquires Biochem Pharmaceuticals
21 Dec 2011
Medical device maker C R Bard acquires Lutonix
21 Dec 2011
Ranbaxy to pay $500 million to settle USFDA ban
21 Dec 2011
Covidien plans to spin off pharmaceuticals business
16 Dec 2011
Covidien’s $2 billion pharmaceuticals business is among the top 10 generic drug makers in the US
Glenmark to market Crofelemer despite Napo nix
15 Dec 2011
AstraZeneca to cut 1,150 sales jobs in the US
08 Dec 2011
Ranbaxy to share Lipitor profits with Teva
02 Dec 2011
Teva today acknowledged that it has entered into a profit-sharing deal with Ranbaxy, but did not provide details of what it was doing to earn that money
Unlimited FDI in pharma sector worries Jena
30 Nov 2011
Merck to pay $950 million to settle Vioxx drug charges
24 Nov 2011
Vioxx was the centre of a long-running probe by the DoJ for Merck having promoted the painkiller without approval
Gilead Sciences to acquire hepatitis C drug developer Pharmasset for $11 bn
21 Nov 2011
Gilead's acquisition of Pharmasset is aimed at diversifying its portfolio to experimental treatments for the hepatitis C virus
Featured articles
![](/Uploads/Images/thumb_733d509d-493c-41e9-b429-1260d912bb91-Aerogel-Crayon.jpg)
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
![](/Uploads/Images/thumb_294b0bec-6ff0-43c9-9fbc-a14e7cc70fa5-COP28.jpg)
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
![](/Uploads/Images/thumb_97943c9b-6e8f-429b-b355-1d4502bac437-Ponzi-Money.jpg)
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
![](/Uploads/Images/thumb_0f8359a3-2528-4faf-86c9-707fb7bccc01-Hdfc-logo.jpg)
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
![](/Uploads/Images/thumb_dc6b9dcc-e31e-4574-82e7-928e089406e0-Finger_millet.jpg)
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
![](/Uploads/Images/thumb_e37827da-fafd-4991-8635-60fade3df34c-ICM.jpg)
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation